Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: Multicenter study of the Korean Cancer Study Group (KCSG).

被引：0

作者：

Chon, Hongjae

Park, Hyung Soon

Kang, Beodeul

Im, Hyeon-Su

Lee, Choong-kun

Kim, Ilhwan

Kang, Myoung Joo

Hwang, Jun-Eul

Kyun, Woo

Cheon, Jaekyung

Hong, Jung Yong

Kang, Jung Hun

Kim, Jung Hoon

Lim, Sung Hee

Kim, Jin Won

Kim, Ji-Won

Yoo, Changhoon

Choi, Hye Jin

Park, Joon Oh

机构：

[1] CHA Hosp, Seongnam, South Korea

[2] Catholic Univ Korea, Div Med Oncol, St Vincents Hosp, Suwon, South Korea

[3] Yonsei Univ, Coll Med, Seoul, South Korea

[4] Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea

[5] Yonsei Univ, Yonsei Canc Ctr, Dept Internal Med, Div Med Oncol,Coll Med, Seoul, South Korea

[6] Haeundae Paik Hosp, Busan, South Korea

[7] Inje Univ, Dept Oncol, Haeundae Paik Hosp, Busan, South Korea

[8] Chonnam Natl Univ, Med Sch, Gwangju, South Korea

[9] Univ Ulsan, Ulsan Univ Hosp, Dept Internal Med, Div Hematol & Oncol,Coll Med, Ulsan, South Korea

[10] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, Seoul, South Korea

[11] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Internal Med, Div Hematol Oncol,Sch Med, Jinju, South Korea

[12] Gyeongsang Natl Univ Hosp, Jinju Si, South Korea

[13] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

[14] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seognnam, South Korea

[15] Yonsei Canc Ctr, Seoul, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4624

引用

页数：2